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In May 2019, the Court of Arbitration for Sport confirmed the 
decision by the International Association of Athletics Federations 
(IAAF) to require hyperandrogenic female athletes such as Caster 
Semenya to reduce their testosterone levels to compete in certain 
races. While Ms Semenya is appealing this decision, the mere fact 
that it was made shows a level of ‘prejudice, discrimination and racial 
bias’ that is unacceptable. As Mahomed and Dhai[1] point out in this 
issue of the SAMJ, gender verification started when women were first 
allowed to participate in the Olympics in 1900, subjecting female 
athletes to invasive, embarrassing and humiliating procedures. These 
many decades of questionable scrutiny of successful female athletes, 
particularly those with backgrounds similar to Ms Semenya’s, have 
shown the IAAF to be disrespectful of human rights and medical 
ethics, exhibiting a level of discrimination that would not be tolerated 
in other areas of international concern. 
The recent ruling comes from Ms Semenya’s challenge to IAAF’s April 
2018 rule change requiring hyperandrogenous athletes to medically 
lower their testosterone levels to below 5 nmol/L for a continuous 
period of at least 6 months. Quite apart from the human rights issues 
involved, this practice is highly unethical – in fact, the World Medical 
Association has warned doctors not to assist in implementing the 
decision. David McQuoid-Mason[2] points out that Semenya and other 
athletes such as Dutee Chand are not ill. Any doctor who ‘treats’ these 
athletes by lowering their testosterone to allow them to compete in 
certain athletic events is therefore not providing healthcare or medical 
treatment, which, even if it were defined as treatment, would be futile. 
Which brings us to an important scientific question – do Ms 
Semenya’s testosterone levels in fact make her faster? Researchers 
affiliated to the IAAF released a study[3] that claimed to show that 
women with high testosterone levels performed as much as 3% better 
than those with lower testosterone levels in a few events. However, the 
findings of this study were challenged by Pielke et al.[4] as unreliable. 
They found significant anomalies and errors in the underlying data 
for the four events that they were able to access, including inclusion of 
times for athletes who had been disqualified by the IAAF for doping, 
duplicated athletes, duplicated times and phantom times – poor 
science that was almost certainly carried through the rest of the data, 
which, tellingly, were withheld. In spite of this the IAAF introduced 
the regulations. 
The discrimination is clear here. Male athletes also have widely 
varying testosterone levels. Their relationship to performance is 
not a matter of scrutiny. Aside from hormones, Nordic skier 
Eero Mäntyranta, for example, has a genetic condition that causes 
excessive production of red blood cells – essentially allowing him 
natural ‘doping’ for endurance events. As Jalme Schultz writes in 
The Conversation,[5] no-one has suggested that Mäntyranta, or other 
men with similar advantages, should muzzle their assets. She also 
points out that there are good reasons for dividing sport into male 
and female categories because there are studies that show that elite 
male athletes outperform elite female athletes by about 10%, so this 
segregation is actually beneficial for women. The tricky part comes 
when you have to decide who is male and who is female and what 
happens when an athlete does not fit neatly into a definition of 
femaleness. And this is where the IAAF and their advisors have fallen 
down so badly, revealing a neat societal definition of ‘femaleness’ 
that defies scientific scrutiny. It is also worth noting that although 
Ms  Semenya outruns most women in her specialist distances, she 
comes nowhere near the times posted by 
elite male athletes over the same distances, 
in spite of having testosterone levels that are 
allegedly ‘male’. Caster Semenya and Dutee 
Chand are legally women and should be 
allowed to compete as such. Let’s hope that 
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